EoCene Ltd. (EOCN) shareholders
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.46−0.07 (-2.77%)
Close on Nov 17, 2026Market cap $2.46MP/E –Yield –
Ownership
Who owns EoCene's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Allen Baharaff | Chief Executive Officer, Director | 100,018 | 1.52% | Mar 18, 2026 |
| Guy Nehemya | Chief Operating Officer | 25,000 | 0.38% | Mar 18, 2026 |
| Yohai Stenzler | Chief Accounting Officer | 25,000 | 0.38% | Mar 18, 2026 |
| Doron Leib Cohen | Chief Financial Officer | 2,083 | 0.03% | Mar 18, 2026 |
| Brueck Liat Nissimov | Chief Scientific Officer | – | – | Mar 18, 2026 |
| Amir Poshinski | Director | 12,500 | 0.19% | Mar 18, 2026 |
| Carol L. Brosgart | Director | – | – | Mar 18, 2026 |
| Shmuel Nir | Director | 12,500 | 0.19% | Mar 18, 2026 |
| David Sidransky | Director | 1,042 | 0.02% | Mar 18, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
1.02%
0M shares short
Days to cover
1.3
At 0M shares a day
Change since last report
+11.7%
From 0M shares
Short volume, 20 days
29.5%
Of volume reported to FINRA
Shares sold short, last 2 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of EoCene's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,750 shares on Sep 29, 2026 over the last 90 days.
See a number that looks wrong?